VTv Therapeutics Profit Margin 2014-2021 | VTVT
Current and historical gross margin, operating margin and net profit margin for VTv Therapeutics (VTVT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. VTv Therapeutics net profit margin as of June 30, 2021 is -71.01%.
|VTv Therapeutics Annual Profit Margins
|VTv Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company's drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina.